Nymox Pharmaceutical Corp (NASDAQ:NYMX)

1.33
Delayed Data
As of Jul 02
 -0.01 / -0.75%
Today’s Change
0.33
Today|||52-Week Range
5.75
+232.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash5.9M1.0M295.5K632.3K
 
 
 
 
 
Short Term Investment Cash-7.3M-4.9M-734.6K336.7K
 
 
 
 
 
Cash & Short Term Investments5.9M1.0M295.5K632.3K
 
 
 
 
 
 
ReceivablesReceivables393.2K617.1K581.0K675.2K
 
 
 
 
 
 
InventoriesInventories23.6K42.5K39.7K88.3K
 
 
 
 
 
 
Current AssetsPrepaid Expenses--32.0K20.3K0.00
 
 
 
Other Current Assets0.0017.4K17.4K--
 
 
 
Current Assets6.3M1.7M953.9K1.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross568.7K548.9K550.2K552.2K
 
 
 
 
 
Depreciation-546.5K-533.8K-537.6K-542.8K
 
 
 
 
 
Other Assets17.4K0.000.000.00
 
 
Total Assets6.4M1.8M966.4K1.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable640.5K880.5K1.4M1.5M
 
 
 
 
 
Accrued Expenses166.9K160.2K106.0K379.3K
 
 
 
 
 
Other Current Liabilities2.8M2.8M2.7M2.9M
 
 
 
 
 
Other Liabilities3.4M3.7M4.1M4.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.00400.0K1.3M
 
 
 
Total Liabilities11.2M8.8M7.0M5.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock400.0K400.0K0.000.00
 
 
 
Common Equity-5.6M-7.8M-6.5M-4.8M
 
 
 
 
 
Total Shareholder Equity-5.2M-7.4M-6.5M-4.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding33.0M33.6M34.7M35.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account